Login to Your Account



Clinic Roundup


Friday, January 18, 2013
• Astex Pharmaceuticals Inc., of Dublin, Calif., is launching a Phase I trial of AT13148, a drug designed to block enzymes controlling cancer cell growth and death.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription